MTH (MTH)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 4/9, Altman Z 4.1. Beneish M-Score of -1.94 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of this entity present a mixed profile where capital efficiency and profitability metrics diverge from revenue trajectory. While the Return on Invested Capital sits at 6.5%, indicating modest generation relative to invested capital, earnings power is driven primarily by margin expansion rather than operational leverage or balance sheet compression; specifically, an ROE decomposition reveals that a net margin of 7.7% and moderate asset turnover of 0.77x are the primary engines for an 8.7% return on equity, supported only slightly by financial leverage at 1.47x. Quality indicators offer conflicting signals: the Piotroski F-Score of 4/9 suggests average financial health with potential weaknesses in profitability or asset quality trends, whereas a Beneish M-Score of -1.94 points toward low earnings manipulation risk, creating an environment where valuation may be disconnected from underlying operational deterioration evidenced by an 8.3% year-over-year revenue contraction.
Valuation metrics currently reflect significant downside compression relative to historical norms and sector peers, trading at a price-to-earnings ratio of 10.5x. This multiple implies that the market has priced in substantial stagnation or further decline given the negative revenue growth, yet it remains difficult to reconcile with the low manipulation risk score without assuming persistent margin erosion. A discount cash flow analysis would likely hinge on whether future free cash flows can stabilize; if implied growth assumptions align with current contraction rates, the 10.5x multiple appears consistent with a distressed asset scenario rather than a value opportunity, suggesting the market is pricing in a continuation of negative operating momentum despite the company's relatively clean earnings profile.
Risk assessment highlights notable divergence between insider behavior and fundamental quality scores. The net selling activity totaling $4.94 million over the last 90 days introduces a counterweight to the low Beneish score, potentially signaling internal skepticism regarding future cash flow generation or capital allocation efficiency that is not yet reflected in the valuation multiple. Combined with the weak revenue trend and mediocre Piotroski F-Score, these factors suggest elevated idiosyncratic risk where downside protection relies heavily on margin resilience rather than growth restoration or balance sheet strengthening.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
⚠️ Dividend consumes >80% of FCF — sustainability risk.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-03-17 | $0.4800 | +11.6% |
| 2025-12-17 | $0.4300 | 0.0% |
| 2025-09-16 | $0.4300 | 0.0% |
| 2025-06-16 | $0.4300 | 0.0% |
| 2025-03-17 | $0.4300 | +14.7% |
| 2024-12-17 | $0.3750 | 0.0% |
| 2024-09-16 | $0.3750 | 0.0% |
| 2024-06-14 | $0.3750 | 0.0% |
| 2024-03-14 | $0.3750 | +177.8% |
| 2023-12-14 | $0.1350 | 0.0% |
| 2023-09-14 | $0.1350 | 0.0% |
| 2023-06-14 | $0.1350 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XHB or SLYV, the fund manager is mechanically forced to buy or sell MTH shares regardless of MTH's individual fundamentals. We estimate $230M of passive capital is structurally linked to MTH through 8 tracked ETFs. Passive flows have a limited but growing influence on MTH's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in MTH to visualize passive redemption contagion across ETFs and collateral stocks.
If MTH (MTH) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies MODINE MANUFACTURING CO (MOD) as the most exposed collateral stock, sharing 1 ETFs with MTH. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 13 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
MTH Ownership Dynamics
Passive funds hold 1 in every 12 MTH shares, reducing daily market volatility.
MTH (MTH) exerts measurable gravity on the passive index market, currently representing 3.5% of the XHB (XHB) and 0.5% of the SLYV (SLYV). Across 14 tracked ETFs, approximately 5M shares (8.2% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.
ETFs with Highest MTH Exposure
Float lock-up computed from 14 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
MTH Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for MTH over the past year sits near $68.69 (11% of 252-day volume). The current price of $68.12 sits 0.8% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
MTH Capital Efficiency
How efficiently does MTH convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
MTH converts 15% of its EBITDA into free cash flow, a low conversion rate suggesting heavy reinvestment. This may indicate a growth phase (building capacity) or structural capital intensity. The 85% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-4.6%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-04 | 82 | $66.34 | $5,439.88 |
| 2026-04-30 | 1,411 | $67.02 | $94,565.22 |
| 2026-04-20 | 519 | $68.07 | $35,328.33 |
| 2026-04-02 | 72 | $62.11 | $4,471.92 |
| 2026-03-31 | 3,366 | $60.07 | $202,195.62 |
| 2026-03-27 | 199 | $60.54 | $12,047.46 |
| 2026-03-20 | 18 | $60.20 | $1,083.6 |
| 2026-03-17 | 58 | $64.13 | $3,719.54 |
| 2026-03-13 | 1 | $62.78 | $62.78 |
| 2026-03-10 | 500 | $68.03 | $34,015 |
| 2026-03-09 | 2 | $67.69 | $135.38 |
| 2026-02-23 | 1,200 | $77.83 | $93,396 |
| 2026-01-21 | 890 | $74.66 | $66,447.4 |
| 2026-01-15 | 1 | $77.08 | $77.08 |
| 2026-01-08 | 1,353 | $66.20 | $89,568.6 |
| 2025-12-12 | 6 | $72.57 | $435.42 |
| 2025-11-28 | 59 | $73.92 | $4,361.28 |
| 2025-11-26 | 314 | $73.05 | $22,937.7 |
| 2025-11-25 | 1,910 | $70.08 | $133,852.8 |
| 2025-11-24 | 508 | $70.29 | $35,707.32 |
| 2025-11-21 | 122 | $65.68 | $8,012.96 |
| 2025-11-10 | 99 | $67.00 | $6,633 |
| 2025-10-28 | 643 | $71.41 | $45,916.63 |
| 2025-10-27 | 10,211 | $71.41 | $729,167.51 |
| 2025-10-23 | 8,530 | $70.67 | $602,815.1 |
| 2025-10-22 | 4,781 | $71.39 | $341,315.59 |
| 2025-10-20 | 13,445 | $70.14 | $943,032.3 |
| 2025-10-17 | 6,714 | $69.79 | $468,570.06 |
| 2025-10-16 | 9,885 | $69.62 | $688,193.7 |
| 2025-10-15 | 17,781 | $69.44 | $1.2M |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| TMHC | 0.917 | 0.893 | High co-movement |
| KBH | 0.898 | 0.861 | High co-movement |
| PHM | 0.890 | 0.870 | High co-movement |
| TOL | 0.881 | 0.847 | High co-movement |
| LEN | 0.855 | 0.798 | High co-movement |
| DHI | 0.854 | 0.859 | High co-movement |
| BLDR | 0.783 | 0.777 | High co-movement |
| NVR | 0.751 | 0.608 | High co-movement |
| BLD | 0.728 | 0.732 | High co-movement |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare MTH to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.